BELKIN Vision

One-second Laser Treatment for Glaucoma

Health Tech & Life Sciences
Acquired (Inactive) by Alcon Pharmaceuticals on Jul 2024 - closed due to acquisition
Follow

Company Overview

Snapshot

Founded in March 2013 by Prof. Belkin, BELKIN Vision operated with 11–50 employees. The company raised $38.44 million across 7 funding rounds from 10 investors. In July 2024, BELKIN Vision was acquired by Alcon Pharmaceuticals.

Business overview

BELKIN Vision is a Health Tech & Life Sciences company specializing in medical devices and treatments for eye diseases. The company developed the Eagle device, a contact-free laser procedure for the primary treatment of glaucoma. This technology delivers a single laser beam to the limbus, enhancing intraocular fluid drainage and lowering intraocular pressure, making it suitable for use in clinics and hospitals as an initial or adjunctive treatment for various types of glaucoma.

Strategic signal

In May 2024, news emerged that Alcon was acquiring BELKIN Vision for up to $330 million, a transaction that was completed in July 2024. This acquisition by a major pharmaceutical company validates BELKIN Vision's innovative approach to glaucoma treatment and signals a significant market opportunity for its contact-free laser technology, indicating strong investor confidence in its commercial potential and impact on the ophthalmology sector.

Log in to access full profile

Company Intelligence Q&A

What was a significant recent corporate development for BELKIN Vision?
In July 2024, BELKIN Vision was acquired by.
Which investors participated in BELKIN Vision's July 2020 funding round?
In July 2020, CR-CP Life Science Fund led a funding round for.
When did BELKIN Vision receive FDA clearance for its Eagle device?
BELKIN Vision announced FDA clearance for its Eagle device in December 2023.
What was the strategic importance of the EU Innovation Council's support for BELKIN Vision?
In December 2021, BELKIN Vision was selected to receive €17.5 million from the EU Innovation Council, providing substantial non-equity funding to advance its glaucoma treatment technology.
When did BELKIN Vision change its corporate name?
BELKIN Laser announced its corporate name change to BELKIN Vision in June 2021.
Log in to access full profile